Download PDF
Thromb Haemost 1997; 77(02): 362-367
DOI: 10.1055/s-0038-1655969
Original Article
Schattauer GmbH Stuttgart

Plasminogen-dependent and -independent Proteolytic Activity of Murine Endothelioma Cells with Targeted Inactivation of Fibrinolytic Genes

H R Lijnen
Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium
,
E F Wagner
1   Institute of Molecular Pathology, Vienna, Austria
,
D Collen
Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received 28 August 1996

Accepted after revision 17 October 1996

Publication Date:
10 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Plasminogen-dependent and -independent proteolytic activity of murine endothelioma (End) cells that were derived from mice with targeted inactivation of the tissue-type plasminogen activator (t-PA -/-), urokinase-type plasminogen activator (u-PA-/-) or plasminogen activator inhibitor-1 (PAI-1 -/- genes was studied with the use of fibrin and extracellular matrix degradation assays. In a buffer milieu, the activation rate of plasminogen (final concentration 0.25 µM) with wild-type and t-PA-/- End cells (3 X 104 to 4 X 106 cells/ml) was comparable, but it was about 4-fold reduced with u-PA -/- End cells and 3-fold enhanced with PAI-1End cells. Plasminogen activation was markedly reduced by addition of amiloride or of anti-murine u-PA antibodies but not by addition of anti-murine t-PA antibodies, and it was not stimulated by addition of fibrin. Lysis of125I-fibrin labeled matrix in the presence of plasminogen was comparable with wild-type, t-PA-/- and PAI-1-/- End cells (50% lysis in 3 h with 0.7 to 1.5 X 106 cells/ml), but was significantly reduced with u-PA-/- End cells (50% lysis in 20 h with 0.87 X 106 cells/ml). Lysis of3H-proline labeled extracellular matrix in the presence of plasminogen with wild-type, t-PA-/- and PAI-1-/- End cells (20% lysis in 48 h with 3 to 5 X 106 cells/ml) was comparable, but it was virtually abolished with u-PA-/- End cells. In the absence of plasminogen, lysis of both the fibrin and the extracellular matrix by all four cell types was drastically reduced and was virtually abolished by addition of phenylmethylsulfonylfluoride or 1,10 phenanthroline.

These data indicate that the proteolytic activity of the transformed murine endothelioma cells, measured in plasminogen activation or matrix degradation assays, is essentially u-PA-related and largely plasminogen-dependent.

 

  • References

  • 1 Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991; 78: 3114-3124
    PubMedSearch in Google Scholar
  • 2 Carmeliet P, Collen D. Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thromb Haemost 1995; 74: 429-436
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Blasi F. Urokinase and urokinase receptor:a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 1993; 15: 105-111
    CrossrefPubMedSearch in Google Scholar
  • 4 Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8 (Suppl. 01) 189-203
    PubMedSearch in Google Scholar
  • 5 Hajjar KA. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 1995; 74: 294-301
    Thieme ConnectPubMedSearch in Google Scholar
  • 6 Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van NuffelenA, Prender-gast G, Cole M, Bronson R, Collen D, Mulligan RC. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 1993; 92: 2746-2755
    CrossrefPubMedSearch in Google Scholar
  • 7 Carmeliet P, Stassen JM, Schoonjans L, Ream B, van denOord JJ, De MolM, Mulligan RC, Collen D. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis,thrombosis, and thrombolysis. J Clin Invest 1993; 92: 2756-2760
    CrossrefPubMedSearch in Google Scholar
  • 8 Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De VosR, van deoord jj, Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994; 368: 419-424
    CrossrefPubMedSearch in Google Scholar
  • 9 Ploplis VA, Carmeliet P, Vazirzadeh S, Van VlaenderenI, Moons L, Plow EF, Collen D. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92: 2585-2593
    CrossrefPubMedSearch in Google Scholar
  • 10 Bugge TH, Flick MJ, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Gene Develop 1995; 09: 794-807
    CrossrefPubMedSearch in Google Scholar
  • 11 Dewerchin M, Van NuffelenA, Wallays G, Bouché A, Moons L, Carmeliet P, Mulligan RC, Collen D. Generation and characterization of urokinase receptor-deficient mice. J Clin Invest 1996; 97: 870-878
    CrossrefPubMedSearch in Google Scholar
  • 12 Bugge TH, Suh TT, Flick MJ, Daugherty C, Rømer JR, Solberg H, Ellis V, Danø K, Degen JL. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 1995; 270: 16886-16894
    CrossrefPubMedSearch in Google Scholar
  • 13 Woessner Jr JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 05: 2145-2154
    CrossrefPubMedSearch in Google Scholar
  • 14 Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Current Opinion in Cell Biology 1995; 07: 728-735
    CrossrefPubMedSearch in Google Scholar
  • 15 Lijnen HR, Van HoefB, De CockF, Collen D. Effect of fibrin-like stimulators on the activation of plasminogen by tissue-type plasminogen activator (t-PA). Studies with active site mutagenized plasminogen and plasmin resistant t-PA. Thromb Haemost 1990; 64: 61-68
    Thieme ConnectPubMedSearch in Google Scholar
  • 16 Lijnen HR, Van HoefB, Beelen V, Collen D. Characterization of the murine plasma fibrinolytic system. Eur J Biochem 1994; 224: 863-871
    CrossrefPubMedSearch in Google Scholar
  • 17 Wagner EF, Sabapathy KT, Kiefer F, Mö hle-SteinleinU, Tacchini-Cottier F, Fetka I, Breier G, Risau W, Montesano R, Pepper MS. Polyoma middle T-induced vascular tumor formation:the role of the plasminogen activator/plasmin system (submitted).
  • 18 Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 1991; 19: 4293
    CrossrefPubMedSearch in Google Scholar
  • 19 Declerck PJ, Verstreken M, Collen D. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Thromb Haemost 1995; 74: 1305-1309
    Thieme ConnectPubMedSearch in Google Scholar
  • 20 Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulphate and copolymerized substrates. Anal Biochem 1980; 102: 196-202
    CrossrefPubMedSearch in Google Scholar
  • 21 Kleiner DE, Stetler-Stevenson WG. Quantitative zymography:detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-329
    CrossrefPubMedSearch in Google Scholar
  • 22 Redlitz A, Plow EF. Receptors for plasminogen and t-PA:an update. Baillière’s Clinical Haematology. 1995; 08: 313-327
    PubMedSearch in Google Scholar
  • 23 Conese M, Blasi F. The urokinase/urokinase-receptor system and cancer invasion. Baillière’s Clinical Haematology 1995; 08: 365-389
    PubMedSearch in Google Scholar
  • 24 Eeckhout Y, Vaes G. Further studies on the activation of procollagenase, the latent precursor of bone collagenase:effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem J 1977; 166: 21-31
    CrossrefPubMedSearch in Google Scholar
  • 25 He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 2632-2636
    CrossrefPubMedSearch in Google Scholar
  • 26 Keski-Oja J, Lohi J, Tuuttila A, Tryggvason K, Vartio T. Proteolytic pro cessing of the 72,000-Da Type IV collagenase by urokinase plasminogen activator. Exp Cell Research 1992; 202: 471-476
    CrossrefPubMedSearch in Google Scholar
  • 27 Marcotte PA, Kozan IM, Dorwin SA, Ryan JM. The matrix metalloproteinase Pump-1 catalyses formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells. J Biol Chem 1992; 267: 13803-13806
    PubMedSearch in Google Scholar